Identification of signature genes and immune infiltration analysis in thyroid cancer based on PANoptosis related genes

• Published in: Frontiers in endocrinology (Lausanne) 2024-07, Vol.15, p.1397794
• Main Authors: Li, Yujie, Wu, Dengqiang
• Format: Article
• Language: English
• Subjects: Biomarkers, Tumor - genetics; candidate genes; Endocrinology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; immune infiltration; Lymphocytes, Tumor-Infiltrating - immunology; PANoptosis; predictive models; Prognosis; Pyroptosis - genetics; thyroid cancer; Thyroid Neoplasms - genetics; Thyroid Neoplasms - immunology; Thyroid Neoplasms - pathology
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2024.1397794

Thyroid cancer is the most common malignancy of the endocrine system. PANoptosis is a specific form of inflammatory cell death. It mainly includes pyroptosis, apoptosis and necrotic apoptosis. There is increasing evidence that PANoptosis plays a crucial role in tumour development. However, no pathogenic mechanism associated with PANoptosis in thyroid cancer has been identified. Based on the currently identified PANoptosis genes, a dataset of thyroid cancer patients from the GEO database was analysed. To screen the common differentially expressed genes of thyroid cancer and PANoptosis. To analyse the functional characteristics of PANoptosis-related genes (PRGs) and screen key expression pathways. The prognostic model was established by LASSO regression and key genes were identified. The association between hub genes and immune cells was evaluated based on the CIBERSORT algorithm. Predictive models were validated by validation datasets, immunohistochemistry as well as drug-gene interactions were explored. The results showed that eight key genes (NUAK2, TNFRSF10B, TNFRSF10C, TNFRSF12A, UNC5B, and PMAIP1) exhibited good diagnostic performance in differentiating between thyroid cancer patients and controls. These key genes were associated with macrophages, CD4+ T cells and neutrophils. In addition, PRGs were mainly enriched in the immunomodulatory pathway and TNF signalling pathway. The predictive performance of the model was confirmed in the validation dataset. The DGIdb database reveals 36 potential therapeutic target drugs for thyroid cancer. Our study suggests that PANoptosis may be involved in immune dysregulation in thyroid cancer by regulating macrophages, CD4+ T cells and activated T and B cells and TNF signalling pathways. This study suggests potential targets and mechanisms for thyroid cancer development.